Pricing Log in Create free account

Arcturus Therapeutics Holdings Inc. (ARCT) vs SAB Biotherapeutics, Inc. (SABS)

Arcturus Therapeutics Holdings Inc. and SAB Biotherapeutics, Inc. are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. and SAB Biotherapeutics, Inc. are of similar size ($267.5M and $266.0M). SAB Biotherapeutics, Inc. grew revenue faster over the last twelve months: −60.3% against −68.7%. SAB Biotherapeutics, Inc. has the higher net margin (0.00% vs −285.9%) and the lower return on invested capital (−39.0% vs 0.00%). Across the 17 metrics below, SAB Biotherapeutics, Inc. leads on 11 and Arcturus Therapeutics Holdings Inc. on 6.

Valuation

Metric ARCT SABS Biotechnology median
P/E n/m n/m 10.60
P/S 9.60 147.02 9.40
P/B 1.74 1.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.02 85.82 9.02
Earnings yield (29.90%) (6.31%) (32.88%)
Free cash flow yield (21.30%) (24.01%) (23.13%)

Profitability

Metric ARCT SABS Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (311.22%) 0.00% 0.00%
Net margin (285.91%) 0.00% 0.00%
Free cash flow margin (204.48%) 0.00% 0.00%
Return on equity (44.37%) (34.27%) (51.96%)
Return on assets (35.06%) (28.97%) (46.06%)
Return on invested capital 0.00% (38.97%) 0.00%

Growth

Metric ARCT SABS Biotechnology median
Revenue growth (TTM) (68.74%) (60.26%) 6.76%
EPS growth (last fiscal year) 20.00% 78.53% 29.88%
Revenue growth, 5-year CAGR 53.78% — 9.75%
Net income growth, 5-year CAGR 0.00% (26.69%) 0.00%

Health

Metric ARCT SABS Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 6.68 9.22 4.97
Net debt to EBITDA 3.15 2.03 1.01

Dividend

Metric ARCT SABS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARCT SABS Biotechnology median
Market cap 266.04m 267.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack